282 related articles for article (PubMed ID: 31205568)
1. Interleukin-35 as an Emerging Player in Tumor Microenvironment.
Xue W; Yan D; Kan Q
J Cancer; 2019; 10(9):2074-2082. PubMed ID: 31205568
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives.
Seif F; Torki Z; Zalpoor H; Habibi M; Pornour M
Mol Ther Oncolytics; 2023 Mar; 28():132-157. PubMed ID: 36816749
[TBL] [Abstract][Full Text] [Related]
3. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
4. The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy.
Lei S; Jin J; Zhao X; Zhou L; Qi G; Yang J
Exp Biol Med (Maywood); 2022 Oct; 247(20):1810-1818. PubMed ID: 35733343
[TBL] [Abstract][Full Text] [Related]
5. Human Adipose Tissue-Derived Mesenchymal Stem Cells in Parkinson's Disease: Inhibition of T Helper 17 Cell Differentiation and Regulation of Immune Balance Towards a Regulatory T Cell Phenotype.
Bi Y; Lin X; Liang H; Yang D; Zhang X; Ke J; Xiao J; Chen Z; Chen W; Zhang X; Wang S; Liu CF
Clin Interv Aging; 2020; 15():1383-1391. PubMed ID: 32884248
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines.
Kinoshita M; Kobayashi S; Gotoh K; Kubo M; Hayashi K; Iwagami Y; Yamada D; Akita H; Noda T; Asaoka T; Takeda Y; Tanemura M; Eguchi H; Urakawa S; Goto K; Maekawa K; Wada H; Mori M; Doki Y
Dig Dis Sci; 2020 Oct; 65(10):2937-2948. PubMed ID: 31853779
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells.
Hao S; Chen X; Wang F; Shao Q; Liu J; Zhao H; Yuan C; Ren H; Mao H
Carcinogenesis; 2018 Dec; 39(12):1488-1496. PubMed ID: 30321288
[TBL] [Abstract][Full Text] [Related]
8. Overview of LAG-3-Expressing, IL-10-Producing Regulatory T Cells.
Fujio K; Yamamoto K; Okamura T
Curr Top Microbiol Immunol; 2017; 410():29-45. PubMed ID: 28929191
[TBL] [Abstract][Full Text] [Related]
9. Changes of Th17 cells, regulatory T cells, Treg/Th17, IL-17 and IL-10 in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Zi C; He L; Yao H; Ren Y; He T; Gao Y
Endocrine; 2022 May; 76(2):263-272. PubMed ID: 35397088
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6-mediated CCR9
Ma F; Li S; Gao X; Zhou J; Zhu X; Wang D; Cai Y; Li F; Yang Q; Gu X; Ge W; Liu H; Xiao X; Hao H
EBioMedicine; 2019 Jun; 44():71-85. PubMed ID: 31129099
[TBL] [Abstract][Full Text] [Related]
12. Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients.
Holzer MT; Almanzar G; Woidich R; Hügle B; Haas JP; Prelog M
Pediatr Rheumatol Online J; 2022 Apr; 20(1):26. PubMed ID: 35410224
[TBL] [Abstract][Full Text] [Related]
13. IL-6: regulator of Treg/Th17 balance.
Kimura A; Kishimoto T
Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-35: Expanding Its Job Profile.
Sawant DV; Hamilton K; Vignali DA
J Interferon Cytokine Res; 2015 Jul; 35(7):499-512. PubMed ID: 25919641
[TBL] [Abstract][Full Text] [Related]
15. Max interacting protein 1 induces IL-17-producing T helper/regulatory T imbalance in osteoarthritis by upregulating tectonic family member 2.
Li X; Xiao S; Li F; Fang K; Wen J; Gong H
Tissue Cell; 2022 Oct; 78():101906. PubMed ID: 36049372
[TBL] [Abstract][Full Text] [Related]
16. Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.
Gnerlich JL; Mitchem JB; Weir JS; Sankpal NV; Kashiwagi H; Belt BA; Porembka MR; Herndon JM; Eberlein TJ; Goedegebuure P; Linehan DC
J Immunol; 2010 Oct; 185(7):4063-71. PubMed ID: 20805420
[TBL] [Abstract][Full Text] [Related]
17. Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective.
Rezalotfi A; Ahmadian E; Aazami H; Solgi G; Ebrahimi M
Front Oncol; 2019; 9():226. PubMed ID: 31024835
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 35: protective role and mechanism in type 1 diabetes.
Zhang SM; Liang J; Xia JP; Li L; Zheng L; Wang YL; Li YH; Li Y; Lu Y
Cent Eur J Immunol; 2023; 48(1):48-53. PubMed ID: 37206590
[TBL] [Abstract][Full Text] [Related]
19. IL-23 and the Tumor Microenvironment.
Subhadarshani S; Yusuf N; Elmets CA
Adv Exp Med Biol; 2021; 1290():89-98. PubMed ID: 33559857
[TBL] [Abstract][Full Text] [Related]
20. Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats.
Long Y; Li S; Qin J; Xie L; Gan L; Jie F; Wu Y; Li Y; Du Q
Biomed Pharmacother; 2018 Sep; 105():781-788. PubMed ID: 29909346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
